Author:
Tavares Adriana Alexandre S.,Barret Olivier,Seibyl John P.,Tamagnan Gilles D.
Publisher
Springer International Publishing
Reference97 articles.
1. Alagille D, Barret O, Vala C et al (2013) Preclinical evaluation of [F-18]MNI-444. A promising PET imaging agent of adenosine A(2a) receptors. J Labelled Cpd Radiopharm 56:S308
2. Angulo E, Casadó V, Mallol J et al (2003) A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol 13:440–451
3. Ascherio A, Zhang SM, Hernán MA et al (2001) Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol 50:56–63
4. Auchampach JA, Kreckler LM, Wan TC et al (2009) Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog. J Pharmacol Exp Ther 329:2–13
5. Bara-Jimenez W, Sherzai A, Dimitrova T et al (2003) Adenosine A2A receptor antagonist treatment of Parkinson’s disease. Neurology 61:293–296